THT BIOMATERIALS GmbH

Founded

2020

Staff

3

Organization type

RDM biotech/pharma

Region

Vienna

Cluster

LISAvienna

Focus

human health

Focus

consumables / reagents

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components (https://tht-biomaterials.com).

R&D:In vitro toxicoty, in vitro diagnostics (cancer)/drug development. Bioaktive tissue-ink. 2D coating/3D gel. Organoids. Filler and wound healing.

Production:HUMAN PLACENTA Collagen-I, liquid or freece-dried. HUMAN PLACENTA Laminin-111. HUMAN PLACENTA Substrate (hpS).